Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Laboratoire d'Hématologie, Pierre-Bénite, France.
Cancer Research Center of Lyon, INSERM 1052 CNRS 5286, Team "Clinical and Experimental Models of Lymphomagenesis", Faculté de Médecine et de Maïeutique Lyon-Sud Charles Mérieux, Oulins, France.
Haematologica. 2017 Oct;102(10):1758-1766. doi: 10.3324/haematol.2016.160192. Epub 2017 Jul 27.
Splenic diffuse red pulp lymphoma is an indolent small B-cell lymphoma recognized as a provisional entity in the World Health Organization 2008 classification. Its precise relationship to other related splenic B-cell lymphomas with frequent leukemic involvement or other lymphoproliferative disorders remains undetermined. We performed whole-exome sequencing to explore the genetic landscape of ten cases of splenic diffuse red pulp lymphoma using paired tumor and normal samples. A selection of 109 somatic mutations was then evaluated in a cohort including 42 samples of splenic diffuse red pulp lymphoma and compared to those identified in 46 samples of splenic marginal zone lymphoma and eight samples of hairy-cell leukemia. Recurrent mutations or losses in (the gene encoding the BCL6 corepressor) - frameshift (n=3), nonsense (n=2), splicing site (n=1), and copy number loss (n=4) - were identified in 10/42 samples of splenic diffuse red pulp lymphoma (24%), whereas only one frameshift mutation was identified in 46 cases of splenic marginal zone lymphoma (2%). Inversely, , and , common mutations in splenic marginal zone lymphoma, were rare (one mutant in 42 samples; 2%) or absent ( and ) in splenic diffuse red pulp lymphoma. These findings define an original genetic profile of splenic diffuse red pulp lymphoma and suggest that the mechanisms of pathogenesis of this lymphoma are distinct from those of splenic marginal zone lymphoma and hairy-cell leukemia.
脾脏弥漫性红髓淋巴瘤是一种惰性小 B 细胞淋巴瘤,被认为是 2008 年世界卫生组织分类中的一个暂定实体。其与其他伴有频繁白血病累及或其他淋巴增生性疾病的相关脾 B 细胞淋巴瘤的确切关系尚未确定。我们使用配对的肿瘤和正常样本,对 10 例脾脏弥漫性红髓淋巴瘤进行了全外显子组测序,以探索其遗传特征。然后,在包括 42 例脾脏弥漫性红髓淋巴瘤样本的队列中评估了 109 个体细胞突变,与在 46 例脾脏边缘区淋巴瘤和 8 例毛细胞白血病样本中鉴定的突变进行了比较。在 10/42 例(24%)脾脏弥漫性红髓淋巴瘤样本中发现了 (编码 BCL6 核心抑制因子的基因)的反复突变或缺失-移码(n=3)、无义(n=2)、剪接位点(n=1)和拷贝数缺失(n=4),而在 46 例脾脏边缘区淋巴瘤中仅发现一个移码突变(2%)。相反,常见于脾脏边缘区淋巴瘤的 、 和 突变在脾脏弥漫性红髓淋巴瘤中很少见(42 例样本中只有一个 突变;2%)或缺失( 和 )。这些发现定义了脾脏弥漫性红髓淋巴瘤的原始遗传特征,并表明该淋巴瘤的发病机制与脾脏边缘区淋巴瘤和毛细胞白血病不同。